COLL vs EMR · P/E 17, rev $181.9M vs P/E 34, rev $4.86B
Collegium Pharmaceutical Inc (COLL) versus Emerson Electric Company (EMR) — a side-by-side from cached financials, not a winner call.
Collegium Pharmaceutical Inc (COLL) is a drug manufacturers - specialty & generic company listed on NASDAQ.
Emerson Electric Company (EMR) is a specialty industrial machinery company listed on NYSE.
Latest reported COLL revenue for 2024-12-31 was $181.9M. Net income was $69.2M. Revenue was up 14.2% from 2024-09-30 to 2024-12-31. COLL currently screens at market cap $1.12B and trailing P/E 16.8.
Latest reported EMR revenue for 2025-09-30 was $4.86B. Net income was $2.25B. Revenue was up 6.6% from 2025-06-30 to 2025-09-30. EMR currently screens at market cap $83.45B and trailing P/E 34.5.
COLL currently screens at market cap $1.12B and trailing P/E 16.8. EMR currently screens at market cap $83.45B and trailing P/E 34.5.
Not investment advice. Open the COLL and EMR stock pages for the full models.
Not investment advice.